Medicare utilization — STACEY RACHELLE KELLY (FNP)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 27,000 | 18 | $0 | $23,836 |
| J0897 | Injection, denosumab, 1 mg | 2,100 | 25 | $0 | $38,838 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 135 | 31 | $0 | $5,465 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 76 | 30 | $0 | $3,544 |
| 96372 | Injection of drug or substance under skin or into muscle | 55 | 14 | $0 | $503 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·